15 dividend stocks beating the S&P 500 as markets sit near record highs
Seeking Alpha News (Wed, 7-Oct 10:47 AM ET)
Barclays Sticks to Their Buy Rating for Elevance Health (ELV)
TipRanks (Wed, 7-Oct 3:57 AM ET)
HHS finalizes updated price transparency rules for healthcare costs
Seeking Alpha News (Mon, 5-Oct 6:18 PM ET)
Business Wire (Mon, 5-Oct 8:00 AM ET)
Bernstein Reaffirms Their Buy Rating on Elevance Health (ELV)
TipRanks (Mon, 5-Oct 7:36 AM ET)
Trump offering $90 to Medicare enrollees to cover premiums
Seeking Alpha News (Sat, 3-Oct 12:33 PM ET)
Business Wire (Thu, 1-Oct 7:00 AM ET)
Business Wire (Thu, 30-Jul 12:00 PM ET)
Market Chameleon (Wed, 15-Jul 3:06 AM ET)
Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
Business Wire (Wed, 15-Jul 6:00 AM ET)
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Elevance Health trades on the NYSE stock market under the symbol ELV.
As of October 7, 2026, ELV stock price climbed to $408.07 with 306,783 million shares trading.
ELV has a beta of 0.75, meaning it tends to be less sensitive to market movements. ELV has a correlation of 0.08 to the broad based SPY ETF.
ELV has a market cap of $88.50 billion. This is considered a Large Cap stock.
Last quarter Elevance Health reported $50 billion in Revenue and $7.45 earnings per share. This beat revenue expectation by $1 billion and exceeded earnings estimates by $1.25.
In the last 3 years, ELV traded as high as $567.26 and as low as $273.71.
The top ETF exchange traded funds that ELV belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
ELV has outperformed the market in the last year with a price return of +18.6% while the SPY ETF gained +16.9%. However, in the short term, ELV had mixed performance relative to the market. It has underperformed in the last 3 months, returning +0.4% vs +3.7% return in SPY. But in the last 2 weeks, ELV shares have fared better than the market returning +1.4% compared to SPY +0.5%.
ELV support price is $393.12 and resistance is $407.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELV shares will trade within this expected range on the day.